News

Cancer loses its sense of time to avoid stress responses

Researchers develop ultrasensitive method to detect low-frequency cancer mutations

ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome

ASH 2025: Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

ASH 2025: Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

ASH 2025: New combination approach aims to make CAR T more durable in lymphoma

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers ​

ASH 2025: ‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukaemia

ASH 2025: Continuous and fixed-duration treatments result in similar outcomes for CLL

Study finds most people trust doctors more than AI but see its potential for cancer diagnosis

ASH 2025: Measurable residual disease shows strong potential as an early indicator of survival in acute myeloid leukaemia

Key protein helps breast cancer cells survive in hostile conditions